Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
The Lancet. Infectious Diseases|September 26, 2022
A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 storyAnanda S Bandyopadhyay, Simona Zipursky
The Journal of Infectious Diseases|January 28, 2025
Global Impact of Mass Vaccination Campaigns on Circulating Type 2 Vaccine-Derived Poliovirus Outbreaks: An Interrupted Time-Series AnalysisLaura V Cooper, Ananda S Bandyopadhyay, Nicholas C Grassly, et al.
Vaccine|March 21, 2022
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experienceGrace R Macklin, Corey Peak, Martin Eisenhawer, et al.
Current Opinion in Infectious Diseases|August 11, 2020
Final frontiers of the polio eradication endgameAnanda S Bandyopadhyay, Grace R Macklin
The Journal of Infectious Diseases|September 30, 2021
Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis EradicationJohn F Modlin, Ananda S Bandyopadhyay, Roland Sutter
Human Vaccines|June 15, 2010
Knowledge and attitudes towards vaccines and immunization among adolescents in South AfricaSimona Zipursky, Charles Shey Wiysonge, Gregory Hussey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2018
Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A ReviewAnanda S Bandyopadhyay, John F Modlin, Jay Wenger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2018
A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of PoliovirusGraciela Matrajt, Brienna Naughton, Ananda S Bandyopadhyay, et al.
Future Microbiology|April 1, 2015
Polio vaccination: past, present and futureAnanda S Bandyopadhyay, Julie Garon, Katherine Seib, et al.
The Lancet. Infectious Diseases|January 21, 2024
Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control studyLaura V Cooper, Tesfaye B Erbeto, Abba A Danzomo, et al.
Pageof 8